Table 2.
Fiber intake and the risk of bladder cancer in the PLCO cohort
| Nutrients | Range (g/day) | Mean (g/day) | Cohort | Cases | Incidence rate (95% CI)a | Age-adjusted HR (95% CI), P-value | Multi-adjusted HR (95% CI),bP-value |
|---|---|---|---|---|---|---|---|
| Total fiber | |||||||
| Q1 | <13.57 | 10.06 | 33 941 | 269 | 6.96 (6.18–7.85) | Reference group | Reference group |
| Q2 | ≥13.57 to <20.01 | 16.62 | 33 884 | 252 | 6.46 (5.71–7.31) | 0.92 (0.77–1.09), P = 0.335 | 0.89 (0.74–1.07), P = 0.225 |
| Q3 | ≥ 20.01 | 27.41 | 33 896 | 255 | 6.52 (5.77–7.37) | 0.93 (0.78–1.10), P = 0.380 | 0.83 (0.66–1.04), P = 0.101 |
| P for trend = 0.378 | P for trend = 0.098 | ||||||
| Insoluble fiber | |||||||
| Q1 | <8.86 | 6.51 | 33 931 | 272 | 7.05 (6.26–7.94) | Reference group | Reference group |
| Q2 | ≥8.86 to <13.19 | 10.90 | 33 918 | 251 | 6.43 (5.68–7.28) | 0.90 (0.76–1.07), P = 0.247 | 0.89 (0.74–1.06), P = 0.199 |
| Q3 | ≥13.19 | 18.16 | 33 872 | 253 | 6.47 (5.72–7.32) | 0.91 (0.76–1.08), P = 0.261 | 0.83 (0.67–1.03), P = 0.095 |
| P for trend = 0.259 | P for trend = 0.092 | ||||||
| Soluble fiber | |||||||
| Q1 | <4.54 | 3.37 | 33 955 | 269 | 6.95 (6.17–7.83) | Reference group | Reference group |
| Q2 | ≥4.54 to <6.68 | 5.55 | 33 987 | 245 | 6.26 (5.53–7.10) | 0.89 (0.75–1.06), P = 0.197 | 0.86 (0.72–1.04), P = 0.114 |
| Q3 | ≥6.68 | 9.19 | 33 779 | 262 | 6.73 (5.96–7.60) | 0.96 (0.81–1.14), P = 0.655 | 0.86 (0.68–1.08), P = 0.184 |
| P for trend = 0.653 | P for trend = 0.168 |
aPer 10 000 person-years.
bAdjusted for age (categorical), sex (male versus female), race (White, Non-Hispanic versus Other), body mass index at the time of enrollment (<25 kg/m2 versus ≥25 kg/m2), education (≤high school versus ≥some college), smoking status (never versus former ≤ 15 years since quit versus former >15 years since quit versus former year since quit unknown versus current smoker ≤1 pack per day versus current smoker >1 pack per day versus current smoker intensity unknown), alcohol drinking status (never versus former versus current), total energy intake (continuous), randomization arm (intervention versus control), family history of any cancer (yes versus no) and marital status (married versus not married).